on-line Ri.MED Symposium "COVID-19: mechanistic dissection, drug development and clinical evaluation"
23 June 2021 - 24 June 2021
Online, Italy
Attendance is free, you just need to fill out the registration form at http://www.fondazionerimed.eu/Contents/PartNews.aspx?id=1271(opens in new window)
Plenary Lecture - Rolf Hilgenfeld, PhD
Director, Institute of Biochemistry, University of Luebeck
Structure-based discovery of SARS-CoV-2 main protease inhibitors
Ugo Perricone, PhD
Group Leader, Molecular Informatics Group, Fondazione RiMED
Multiple in silico approaches in the discovery of Sars-CoV-2 inhibitors
Mathias Munschauer, PhD
Junior Group Leader, Helmholtz Institute for RNA-based Infection Research
The SARS-CoV-2 RNA–protein interactome in infected human cells
Claudia Coronnello, PhD
Senior Scientist in Computational Biology, Advanced Data Analysis Group, Fondazione RiMED
SARS-CoV-2 as competing endogenous RNA of host's microRNA
Andreas Schlundt, PhD
Group Leader, Institute of Molecular Biosciences and Biomagnetic Resonance Center (BMRZ), Goethe University Frankfurt
Covid19-NMR: A holistic NMR-based screen for the druggability of SARS-CoV-2 RNAs and proteome
Caterina Alfano, PhD
Group Leader, Structural Biology and Biophysics Group, Fondazione RiMED
Structural elucidation of SARS-CoV-2 protein targets
Plenary Lecture - Andrea Gambotto, MD
Associate Professor of Surgery, University of Pittsburgh
Giovanna Panarello, MD
Chief of Intensive Care Unit, IRCCS ISMETT
Impact of ECMO rescue during SARS-COVID 2 pandemic in Sicily
Camillo Ricordi, MD, PhD
Director of the Diabetes Research Institute (DRI), Director of the Cell Transplant Program, University of Miami
Umbilical Cord derived Mesenchymal Stem Cells in the Treatment of COVID-19 ARDS
Albert Comelli, PhD
Scientist in Nuclear Magnetic Resonance, Advanced Data Analysis Group, Fondazione RiMED
Efficient Neural Network for COVID-19 infected region identification in CT images
Anthony R. Cillo, PhD
Postdoctoral Associate, Department of Immunology, University of Pittsburgh
Immune signatures are predictive of outcome in critically ill COVID-19 patients
Monica Miele, PhD, GMP Production Manager, Fondazione RiMED and Matteo Bulati, PhD, Senior Scientist in Immunology, IRCCS ISMETT
A pilot comparative study of SARS-CoV-2 mRNA vaccine on immunocompetent versus solid organ transplanted (SOT) recipients
Plenary Lecture - Rolf Hilgenfeld, PhD
Director, Institute of Biochemistry, University of Luebeck
Structure-based discovery of SARS-CoV-2 main protease inhibitors
Ugo Perricone, PhD
Group Leader, Molecular Informatics Group, Fondazione RiMED
Multiple in silico approaches in the discovery of Sars-CoV-2 inhibitors
Mathias Munschauer, PhD
Junior Group Leader, Helmholtz Institute for RNA-based Infection Research
The SARS-CoV-2 RNA–protein interactome in infected human cells
Claudia Coronnello, PhD
Senior Scientist in Computational Biology, Advanced Data Analysis Group, Fondazione RiMED
SARS-CoV-2 as competing endogenous RNA of host's microRNA
Andreas Schlundt, PhD
Group Leader, Institute of Molecular Biosciences and Biomagnetic Resonance Center (BMRZ), Goethe University Frankfurt
Covid19-NMR: A holistic NMR-based screen for the druggability of SARS-CoV-2 RNAs and proteome
Caterina Alfano, PhD
Group Leader, Structural Biology and Biophysics Group, Fondazione RiMED
Structural elucidation of SARS-CoV-2 protein targets
Plenary Lecture - Andrea Gambotto, MD
Associate Professor of Surgery, University of Pittsburgh
Giovanna Panarello, MD
Chief of Intensive Care Unit, IRCCS ISMETT
Impact of ECMO rescue during SARS-COVID 2 pandemic in Sicily
Camillo Ricordi, MD, PhD
Director of the Diabetes Research Institute (DRI), Director of the Cell Transplant Program, University of Miami
Umbilical Cord derived Mesenchymal Stem Cells in the Treatment of COVID-19 ARDS
Albert Comelli, PhD
Scientist in Nuclear Magnetic Resonance, Advanced Data Analysis Group, Fondazione RiMED
Efficient Neural Network for COVID-19 infected region identification in CT images
Anthony R. Cillo, PhD
Postdoctoral Associate, Department of Immunology, University of Pittsburgh
Immune signatures are predictive of outcome in critically ill COVID-19 patients
Monica Miele, PhD, GMP Production Manager, Fondazione RiMED and Matteo Bulati, PhD, Senior Scientist in Immunology, IRCCS ISMETT
A pilot comparative study of SARS-CoV-2 mRNA vaccine on immunocompetent versus solid organ transplanted (SOT) recipients
Keywords
Covid-19, SARS-CoV-2, Structural elucidation of SARS-CoV-2 protein targets, ECMO rescue, Neural Network, Treatment of COVID-19 ARDS, SARS-CoV-2 mRNA vaccine, SARS-CoV-2 RNA protein interactome, main protease inhibitors, Structural Biology, Computational Biology, Advanced Data Analysis, Molecular Informatics, Biochemistry, CT images